Sign up to save your podcasts
Or
Share Navigating Pharma: From FDA Challenges to Consulting with Kimberly Wallbank
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Navigating Pharma: From FDA Challenges to Consulting with Kimberly Wallbank
Kyle Goodknight introduces Kimberly Wallbank, who shares her expertise on quality systems and navigating FDA consent decree challenges. The discussion covers effective corporate communication, process improvement, and the use of relatable analogies in consulting. Kimberly addresses internal resistance within the pharmaceutical industry and the intricacies of performance reviews and corporate politics. They delve into medical device recalls, FDA reporting, and Kimberly's transition from a corporate role to consulting. She offers entrepreneurial advice, discusses consulting market challenges, and provides an overview of her consulting services.
Kimberly Wallbank is a distinguished Quality Systems and Regulatory Consultant with over 27 years of industry experience. She is the founder and owner of Quality Systems Services LLC. Kimberly possesses extensive expertise in guiding pharmaceutical, biotechnology, and medical device companies towards achieving compliance with FDA, EMEA, ISO, and other recognized standards.
LinkedIn: / kimberlywallbank
WEBSITE: https://www.qualitysystemsservices.com/
WEBSITE: https://www.qualitysystemsservices.com/
Her vast experience includes establishing, maintaining, and enhancing quality systems to ensure the delivery of world-class healthcare. As an industry leader, Kimberly adeptly navigates the complexities of FDA compliance while optimizing processes tailored to the unique needs of each business.
Kimberly holds a Bachelor of Science degree from Marquette University and a Master of Business Administration from the University of Phoenix.
(0:00) Introduction of Kimberly Wallbank and Episode Overview
(2:16) Quality Systems and FDA Consent Decree Challenges
(4:46) Corporate Communication and Process Improvement
(7:21) Consulting with Relatable Analogies
(10:56) Internal Resistance in the Pharmaceutical Industry
(14:00) Performance Reviews and Corporate Politics
(18:07) Medical Device Recalls and FDA Reporting
(23:37) Transition from Corporate to Consulting
(28:30) Entrepreneurial Advice from Kimberly Wallbank
(32:07) Consulting Market Challenges
(36:34) Overview of Kimberly's Consulting Services
(41:06) Contacting Kimberly Wallbank
(43:28) Personal Interests: Hockey and More
(46:41) Career Paths in Science and Transitions to Industry
(47:49) Documentation Importance in Scientific Careers
(48:24) Industry Challenges for New Graduates
(49:32) Final Thoughts and Episode Takeaways
(50:09) Closing Remarks and Call to Action
View all episodes
By Kyle GoodknightKyle Goodknight introduces Kimberly Wallbank, who shares her expertise on quality systems and navigating FDA consent decree challenges. The discussion covers effective corporate communication, process improvement, and the use of relatable analogies in consulting. Kimberly addresses internal resistance within the pharmaceutical industry and the intricacies of performance reviews and corporate politics. They delve into medical device recalls, FDA reporting, and Kimberly's transition from a corporate role to consulting. She offers entrepreneurial advice, discusses consulting market challenges, and provides an overview of her consulting services.
Kimberly Wallbank is a distinguished Quality Systems and Regulatory Consultant with over 27 years of industry experience. She is the founder and owner of Quality Systems Services LLC. Kimberly possesses extensive expertise in guiding pharmaceutical, biotechnology, and medical device companies towards achieving compliance with FDA, EMEA, ISO, and other recognized standards.
LinkedIn: / kimberlywallbank
WEBSITE: https://www.qualitysystemsservices.com/
WEBSITE: https://www.qualitysystemsservices.com/
Her vast experience includes establishing, maintaining, and enhancing quality systems to ensure the delivery of world-class healthcare. As an industry leader, Kimberly adeptly navigates the complexities of FDA compliance while optimizing processes tailored to the unique needs of each business.
Kimberly holds a Bachelor of Science degree from Marquette University and a Master of Business Administration from the University of Phoenix.
(0:00) Introduction of Kimberly Wallbank and Episode Overview
(2:16) Quality Systems and FDA Consent Decree Challenges
(4:46) Corporate Communication and Process Improvement
(7:21) Consulting with Relatable Analogies
(10:56) Internal Resistance in the Pharmaceutical Industry
(14:00) Performance Reviews and Corporate Politics
(18:07) Medical Device Recalls and FDA Reporting
(23:37) Transition from Corporate to Consulting
(28:30) Entrepreneurial Advice from Kimberly Wallbank
(32:07) Consulting Market Challenges
(36:34) Overview of Kimberly's Consulting Services
(41:06) Contacting Kimberly Wallbank
(43:28) Personal Interests: Hockey and More
(46:41) Career Paths in Science and Transitions to Industry
(47:49) Documentation Importance in Scientific Careers
(48:24) Industry Challenges for New Graduates
(49:32) Final Thoughts and Episode Takeaways
(50:09) Closing Remarks and Call to Action